the combination of hormonal treatment based on a long-acting delivery system for the agonist [ 6-d-tryptophan ] luteinizing hormone-releasing hormone ( [ d-trp6 ] -lh-rh ) with the chemotherapeutic agent novantrone ( mitoxantrone dihydrochloride ) was studied in the dunning r3327h rat prostate cancer model .
C0282248
novantrone
C0700458
mitoxantrone